Douglas L. Packer, MD, FHRS

Dr. Packer is internationally known in cardiac electrophysiology and currently is at the Intermountain Medical Center. He was the past John M. Nasseff, Sr., Professor in Cardiovascular Diseases, at Mayo Clinic,. and the Director of the Translational Electrophysiology Research Laboratory. He completed an internship, residency and fellowship at Duke University, where he was on staff before coming to Mayo. His honors and awards include the ACC 2019 Distinguished Scientist Award (Translational) (2019). Dr. Packer is active in the Heart Rhythm Society where he is a past president. Dr. Packer lectures widely on cardiac arrhythmias. He has written or co-authored more than 419 publications and 644 abstracts. He has lectured extensively in national and international meetings, giving over 1,872 invited lectures in 41 countries. He has served on the executive committee of the NIH MUSTT, SCD-HeFT, and HAT Trials. Dr. Packer is also the International Principal Investigator of the CABANA and the Upcoming CABANA HF Trial.
His translational work focuses on the mechanisms and ablation of AF and VT, autologous fibroblast modulation of electrical impulse propagation, and the development of particle therapy for catheter-free ablation of arrhythmias. His clinical work investigates 4/5 dimensional integrated image-guided ablation, and the development of new energy sources for the modification of cardiac tissue. His work has been funded in part by private foundations, the American Heart Association, and the NIH. Dr. Packer holds US and European patents in the development of intracardiac ultrasound, 4/5D imaging, and particle therapy ablation.